← Browse by Condition
Medical Condition

non squamous non small cell lung cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07264816 Phase 2
Recruiting

A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC

Enrollment
80 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
View Trial →